相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Honokiol antagonizes doxorubicin resistance in human breast cancer via miR-188-5p/FBXW7/c-Myc pathway
Xianglan Yi et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2021)
Crucial players in glycolysis: Cancer progress
Zaka Abbaszadeh et al.
GENE (2020)
Solute carrier transporters: the metabolic gatekeepers of immune cells
Wenxin Song et al.
ACTA PHARMACEUTICA SINICA B (2020)
Deubiquitylase OTUD6B Governs pVHL Stability in an Enzyme-Independent Manner and Suppresses Hepatocellular Carcinoma Metastasis
Xinxin Liu et al.
ADVANCED SCIENCE (2020)
Sevoflurane preconditioning attenuates hypoxia/reoxygenation injury of H9c2 cardiomyocytes by activation of the HIF-1/PDK-1 pathway
Tianliang Hou et al.
PEERJ (2020)
The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression
Peter Vaupel et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2019)
Proliferating tumor cells mimick glucose metabolism of mature human erythrocytes
Mehrdad Ghashghaeinia et al.
CELL CYCLE (2019)
Honokiol for cancer therapeutics: A traditional medicine that can modulate multiple oncogenic targets
Kishore Banik et al.
PHARMACOLOGICAL RESEARCH (2019)
Metabolic crosstalk in the breast cancer microenvironment
Ana S. Dias et al.
EUROPEAN JOURNAL OF CANCER (2019)
Honokiol: An anticancer lignan
Abdur Rauf et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Honokiol targets mitochondria to halt cancer progression and metastasis
Jing Pan et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2016)
Hypoxia and metabolic adaptation of cancer cells
K. L. Eales et al.
ONCOGENESIS (2016)
Cancer metabolism and the Warburg effect: the role of HIF-1 and PI3K
Rupert Courtnay et al.
MOLECULAR BIOLOGY REPORTS (2015)
HIF-1α pathway: role, regulation and intervention for cancer therapy
Georgina N. Masoud et al.
ACTA PHARMACEUTICA SINICA B (2015)
Cancer as a metabolic disease: implications for novel therapeutics
Thomas N. Seyfried et al.
CARCINOGENESIS (2014)
Evaluation of Anti-HIF and Anti-Angiogenic Properties of Honokiol for the Treatment of Ocular Neovascular Diseases
Divya Teja Vavilala et al.
PLOS ONE (2014)
Tumor glycolysis as a target for cancer therapy: progress and prospects
Shanmugasundaram Ganapathy-Kanniappan et al.
MOLECULAR CANCER (2013)
HIF-1α stimulates aromatase expression driven by prostaglandin E2 in breast adipose stroma
Nirukshi U. Samarajeewa et al.
BREAST CANCER RESEARCH (2013)
Honokiol inhibits HIF pathway and hypoxia-induced expression of histone lysine demethylases
Divya Teja Vavilala et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Aerobic Glycolysis: Meeting the Metabolic Requirements of Cell Proliferation
Sophia Y. Lunt et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 27 (2011)
Hypoxia-inducible factor 1: Regulator of mitochondrial metabolism and mediator of ischemic preconditioning
Gregg L. Semenza
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
Honokiol inhibits hypoxia-inducible factor-1 pathway
Keng-Li Lan et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2011)
Oxygen Sensing, Homeostasis, and Disease
David De Bels et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Overexpression of the HIF Hydroxylases PHD1, PHD2, PHD3 and FIH Are Individually and Collectively Unfavorable Prognosticators for NSCLC Survival
Sigve Andersen et al.
PLOS ONE (2011)
MECHANISMS OF DISEASE Oxygen Sensing, Homeostasis, and Disease
Gregg L. Semenza
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Hsp70 and CHIP Selectively Mediate Ubiquitination and Degradation of Hypoxia-inducible Factor (HIF)-1α but Not HIF-2α
Weibo Luo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Tumor cell metabolism: Cancer's Achilles' heel
Guido Kroemer et al.
CANCER CELL (2008)
HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia
JW Kim et al.
CELL METABOLISM (2006)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
分享论文
